{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T00:15:01Z","timestamp":1648599301883},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2009,10,16]],"date-time":"2009-10-16T00:00:00Z","timestamp":1255651200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1007\/s00108-009-2468-x","type":"journal-article","created":{"date-parts":[[2009,10,14]],"date-time":"2009-10-14T19:02:49Z","timestamp":1255546969000},"page":"1191-1199","source":"Crossref","is-referenced-by-count":0,"title":["Karotisstenose"],"prefix":"10.1007","volume":"50","author":[{"given":"A.","family":"Chatzikonstantinou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.G.","family":"Hennerici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,10,16]]},"reference":[{"key":"2468_CR1","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1161\/STROKEAHA.108.534107","volume":"40","author":"Amarenco","year":"2009","unstructured":"Amarenco P, Benavente O, Goldstein LB et al. (2009) Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial by stroke subtypes. Stroke 40: 1405\u20131409","journal-title":"Stroke"},{"key":"2468_CR2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.atherosclerosis.2008.09.008","volume":"204","author":"Amarenco","year":"2009","unstructured":"Amarenco P, Goldstein LB, Callahan AR et al. (2009) Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Atherosclerosis 204: 515\u2013520","journal-title":"Atherosclerosis"},{"key":"2468_CR3","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1503\/cmaj.1040725","volume":"171","author":"Barnett","year":"2004","unstructured":"Barnett HJ (2004) The inappropriate use of carotid endarterectomy. CMAJ 171: 473\u2013474","journal-title":"CMAJ"},{"key":"2468_CR4","first-page":"1169","volume":"166","author":"Barnett","year":"2002","unstructured":"Barnett HJ, Meldrum HE, Eliasziw M (2002) The appropriate use of carotid endarterectomy. CMAJ 166: 1169\u20131179","journal-title":"CMAJ"},{"key":"2468_CR5","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1056\/NEJM198610023151404","volume":"315","author":"Chambers","year":"1986","unstructured":"Chambers BR, Norris JW (1986) Outcome in patients with asymptomatic neck bruits. N Engl J Med 315: 860\u2013865","journal-title":"N Engl J Med"},{"key":"2468_CR6","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1161\/STROKEAHA.109.553545","volume":"40","author":"Cucchiara","year":"2009","unstructured":"Cucchiara BL, Messe SR, Sansing L et al. (2009) Lipoprotein-associated phospholipase A2 and C-reactive protein for risk-stratification of patients with TIA. Stroke 40: 2332\u20132336","journal-title":"Stroke"},{"key":"2468_CR7","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1001\/jama.1975.03260100053020","volume":"233","author":"DeBakey","year":"1975","unstructured":"DeBakey ME (1975) Successful carotid endarterectomy for cerebrovascular insufficiency. Nineteen-year follow-up. JAMA 233: 1083\u20131085","journal-title":"JAMA"},{"key":"2468_CR8","doi-asserted-by":"crossref","unstructured":"Diener HC (2008) Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie. Thieme, Stuttgart","DOI":"10.1055\/b-002-19458"},{"key":"2468_CR9","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1161\/01.STR.0000209331.39894.3d","volume":"37","author":"Dittrich","year":"2006","unstructured":"Dittrich R, Ritter MA, Kaps M et al. (2006) The use of embolic signal detection in multicenter trials to evaluate antiplatelet efficacy: signal analysis and quality control mechanisms in the CARESS (Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic carotid Stenosis) trial. Stroke 37: 1065\u20131069","journal-title":"Stroke"},{"key":"2468_CR10","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/S0140-6736(54)90544-9","volume":"267","author":"Eastcott","year":"1954","unstructured":"Eastcott HH, Pickering GW, Rob CG (1954) Reconstruction of internal carotid artery in a patient with intermittent attacks of hemiplegia. Lancet 267: 994\u2013996","journal-title":"Lancet"},{"key":"2468_CR11","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1503\/cmaj.1030460","volume":"170","author":"Eliasziw","year":"2004","unstructured":"Eliasziw M, Kennedy J, Hill MD et al. (2004) Early risk of stroke after a transient ischemic attack in patients with internal carotid artery disease. CMAJ 170: 1105\u20131109","journal-title":"CMAJ"},{"key":"2468_CR12","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1001\/jama.1995.03520420037035","volume":"273","author":"Executive","year":"1995","unstructured":"Executive Committee for the Asymptomatic Carotid Atherosclerosis Study (1995) Endarterectomy for asymptomatic carotid artery stenosis. JAMA 273: 1421\u20131428","journal-title":"JAMA"},{"key":"2468_CR13","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1161\/STROKEAHA.109.547497","volume":"40","author":"Gladstone","year":"2009","unstructured":"Gladstone DJ, Oh J, Fang J et al. (2009) Urgency of carotid endarterectomy for secondary stroke prevention: results from the Registry of the Canadian Stroke Network. Stroke 40: 2776\u20132782","journal-title":"Stroke"},{"key":"2468_CR14","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/bjs.1800841214","volume":"84","author":"Golledge","year":"1997","unstructured":"Golledge J, Cuming R, Ellis M et al. (1997) Carotid plaque characteristics and presenting symptom. Br J Surg 84: 1697\u20131701","journal-title":"Br J Surg"},{"key":"2468_CR15","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S0140-6736(04)16146-1","volume":"363","author":"Halliday","year":"2004","unstructured":"Halliday A, Mansfield A, Marro J et al. (2004) Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet 363: 1491\u20131502","journal-title":"Lancet"},{"key":"2468_CR16","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1161\/01.STR.12.6.750","volume":"12","author":"Hennerici","year":"1981","unstructured":"Hennerici M, Aulich A, Sandmann W et al. (1981) Incidence of asymptomatic extracranial arterial disease. Stroke 12: 750\u2013758","journal-title":"Stroke"},{"key":"2468_CR17","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/brain\/110.3.777","volume":"110","author":"Hennerici","year":"1987","unstructured":"Hennerici M, H\u00fclsb\u00f6mer HB, Hefter H et al. (1987) Natural history of asymptomatic extracranial arterial disease. Results of a long-term prospective study. Brain 110: 777\u2013791","journal-title":"Brain"},{"key":"2468_CR18","unstructured":"Hennerici MG, Neuerburg-Heussler D (2006) Vascular diagnosis with ultrasound, vol 1. Thieme, Stuttgart New York"},{"key":"2468_CR19","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(07)60150-0","volume":"369","author":"Johnston","year":"2007","unstructured":"Johnston SC, Rothwell PM, Nguyen-Huynh MN et al. (2007) Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet 369: 283\u2013292","journal-title":"Lancet"},{"key":"2468_CR20","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.jvs.2008.10.059","volume":"49","author":"Kakkos","year":"2009","unstructured":"Kakkos SK, Sabetai M, Tegos T et al. (2009) Silent embolic infarcts on computed tomography brain scans and risk of ipsilateral hemispheric events in patients with asymptomatic internal carotid artery stenosis. J Vasc Surg 49: 902\u2013909","journal-title":"J Vasc Surg"},{"key":"2468_CR21","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/ncpneuro0470","volume":"3","author":"Kern","year":"2007","unstructured":"Kern R, Ringleb PA, Hacke W et al. (2007) Stenting for carotid artery stenosis. Nat Rev Neurol 3: 212\u2013220","journal-title":"Nat Rev Neurol"},{"key":"2468_CR22","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1056\/NEJMoa035655","volume":"349","author":"Kolodgie","year":"2003","unstructured":"Kolodgie FD, Gold HK, Burke AP et al. (2003) Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 349: 2316\u20132325","journal-title":"N Engl J Med"},{"key":"2468_CR23","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1007\/s00115-006-2145-4","volume":"77","author":"Lanczik","year":"2006","unstructured":"Lanczik O, B\u00e4zner H, Hennerici MG et al. (2006) Asymptomatic carotid stenoses. Course and discussion of their treatment. Nervenarzt 77 (Suppl 1): S5\u2013S12","journal-title":"Nervenarzt"},{"key":"2468_CR24","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","volume":"420","author":"Libby","year":"2002","unstructured":"Libby P (2002) Inflammation in atherosclerosis. Nature 420: 868\u2013874","journal-title":"Nature"},{"key":"2468_CR25","doi-asserted-by":"crossref","unstructured":"(n a) (1998) Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 351: 1379\u20131387","DOI":"10.1016\/S0140-6736(97)09292-1"},{"key":"2468_CR26","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1056\/NEJM199108153250701","volume":"325","author":"North","year":"1991","unstructured":"North American Symptomatic Carotid Endarterectomy Trial Collaborators (1991) Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 325: 445\u2013453","journal-title":"N Engl J Med"},{"key":"2468_CR27","first-page":"328","volume":"1","author":"Ries","year":"1996","unstructured":"Ries S, Schminke U, Daffertshofer M et al. (1996) High intensity transient signals (HITS) in patients with carotid artery disease. Eur J Med Res 1: 328\u2013330","journal-title":"Eur J Med Res"},{"key":"2468_CR28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000074801","volume":"17","author":"Rothwell","year":"2004","unstructured":"Rothwell PM (2004) Effective stroke prevention in patients with symptomatic carotid stenosis. Cerebrovasc Dis 17 (Suppl 1): 89\u2013104","journal-title":"Cerebrovasc Dis"},{"key":"2468_CR29","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1161\/01.STR.0000054671.71777.C7","volume":"34","author":"Rothwell","year":"2003","unstructured":"Rothwell PM, Gutnikov SA, Warlow CP (2003) Reanalysis of the final results of the European Carotid Surgery Trial. Stroke 34: 514\u2013523","journal-title":"Stroke"},{"key":"2468_CR30","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1161\/STROKEAHA.108.516450","volume":"39","author":"Sillesen","year":"2008","unstructured":"Sillesen H, Amarenco P, Hennerici MG et al. (2008) Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke 39: 3297\u20133302","journal-title":"Stroke"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-009-2468-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-009-2468-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-009-2468-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T00:12:15Z","timestamp":1558570335000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-009-2468-x"}},"subtitle":["Ist die Unterteilung in symptomatisch und asymptomatisch obsolet?"],"short-title":[],"issued":{"date-parts":[[2009,10,16]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["2468"],"URL":"https:\/\/doi.org\/10.1007\/s00108-009-2468-x","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,16]]}}}